| Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 ER Dorsey, R Constantinescu, JP Thompson, KM Biglan, RG Holloway, ... Neurology 68 (5), 384-386, 2007 | 3321 | 2007 |
| The Parkinson progression marker initiative (PPMI) K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ... Progress in neurobiology 95 (4), 629-635, 2011 | 1591 | 2011 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ... Movement Disorders 26 (S3), S2-S41, 2011 | 829 | 2011 |
| DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers CF Lippa, JE Duda, M Grossman, HI Hurtig, D Aarsland, BF Boeve, ... Neurology 68 (11), 812-819, 2007 | 691 | 2007 |
| Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review):[RETIRED] Report of the Quality Standards … JM Miyasaki, K Shannon, V Voon, B Ravina, G Kleiner-Fisman, ... Neurology 66 (7), 996-1002, 2006 | 690 | 2006 |
| Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group B Ravina, K Marder, HH Fernandez, JH Friedman, W McDonald, ... Movement Disorders 22 (8), 1061-1068, 2007 | 584 | 2007 |
| The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease DJ Gill, A Freshman, JA Blender, B Ravina Movement disorders: official journal of the Movement Disorder Society 23 (7 …, 2008 | 519 | 2008 |
| Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ... The American Journal of Human Genetics 98 (3), 500-513, 2016 | 418 | 2016 |
| The impact of depressive symptoms in early Parkinson disease B Ravina, R Camicioli, PG Como, L Marsh, J Jankovic, D Weintraub, ... Neurology 69 (4), 342-347, 2007 | 409 | 2007 |
| Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ... Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014 | 386 | 2014 |
| The role of radiotracer imaging in Parkinson disease B Ravina, D Eidelberg, JE Ahlskog, RL Albin, DJ Brooks, M Carbon, ... Neurology 64 (2), 208-215, 2005 | 383 | 2005 |
| Gene therapy for neurological disorders: progress and prospects BE Deverman, BM Ravina, KS Bankiewicz, SM Paul, DWY Sah Nature Reviews Drug Discovery 17 (9), 641-659, 2018 | 357 | 2018 |
| Donepezil for dementia in Parkinson’s disease: a randomised, double blind, placebo controlled, crossover study B Ravina, M Putt, A Siderowf, JT Farrar, M Gillespie, A Crawley, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 934-939, 2005 | 353 | 2005 |
| Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment BM Ravina, SC Fagan, RG Hart, CA Hovinga, DD Murphy, TM Dawson, ... Neurology 60 (8), 1234-1240, 2003 | 340 | 2003 |
| Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation S Hague, E Rogaeva, D Hernandez, C Gulick, A Singleton, M Hanson, ... Annals of neurology 54 (2), 271-274, 2003 | 327 | 2003 |
| Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group L Marsh, WM McDonald, J Cummings, B Ravina, ... Movement disorders 21 (2), 148-158, 2006 | 312 | 2006 |
| Mortality in Friedreich ataxia AY Tsou, EK Paulsen, SJ Lagedrost, SL Perlman, KD Mathews, ... Journal of the neurological sciences 307 (1-2), 46-49, 2011 | 308 | 2011 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 300 | 2014 |
| Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's G Liu, B Boot, JJ Locascio, IE Jansen, S Winder‐Rhodes, S Eberly, ... Annals of neurology 80 (5), 674-685, 2016 | 260 | 2016 |
| Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety T Simuni, JL Jaggi, H Mulholland, HI Hurtig, A Colcher, AD Siderowf, ... Journal of neurosurgery 96 (4), 666-672, 2002 | 175 | 2002 |
